Congenital deafness affects roughly one in 1,000 babies and is often linked to genetic mutations, many of which remain unidentified.

Learn about Colossal's dire wolf de-extinction breakthrough and how this technology could reshape conservation.

New candidate genes which could be responsible for deafness have been identified. Congenital deafness (hearing loss from ...

After 12,000 years, the Dire Wolves have been brought back from extinction thanks to the expert team at Colossal Biosciences, ...

The hypothalamus is a small but critical region at the base of the brain that controls the autonomic nervous system, ...

This study fills a crucial gap in our understanding of blood cell formation from human pluripotent stem cells (hPSCs). Genome-wide comparisons of hPSC-derived blood progenitor cells with in vivo blood ...

A study reporting on DiscGenics’ cell therapy phase 1 and 2 study has been selected as one of three of the best and most influential articles published in the International Journal of Spine Surgery in ...

Ethical debates regarding Colossal Biosciences’s achievements and over-marketing aside, the company behind woolly mice is ...

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the ...

In a new study published in Developmental Cell on April 8, a research team led by Prof. WU Qingfeng at the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences has ...

Organoids are made to model human organs and are promising for research and therapy, but there are limitations to their ...